Cart
sales@molnova.com
Methylophiopogonanone B
CAS No. 74805-91-7
Methylophiopogonanone B( —— )
Catalog No. M19070 CAS No. 74805-91-7
Methylophiopogonanone B (MOPB) induces cell morphological change and Rho activation via melanocyte dendrite retraction and stress fiber formation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 202 | In Stock |
|
| 5MG | 188 | In Stock |
|
| 10MG | 312 | In Stock |
|
| 25MG | 524 | In Stock |
|
| 50MG | 732 | In Stock |
|
| 100MG | 995 | In Stock |
|
| 200MG | 1330 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethylophiopogonanone B
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethylophiopogonanone B (MOPB) induces cell morphological change and Rho activation via melanocyte dendrite retraction and stress fiber formation.
-
DescriptionMethylophiopogonanone B (MOPB) induces cell morphological change and Rho activation via melanocyte dendrite retraction and stress fiber formation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number74805-91-7
-
Formula Weight328.36
-
Molecular FormulaC19H20O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (304.54 mM)
-
SMILESCC1=C(C2=C(C(=C1O)C)OCC(C2=O)CC3=CC=C(C=C3)OC)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SP420
SP-420 is a novel orally active iron chelator.
-
D-Glucose 6-phosphat...
In cells D-glucose 6-phosphate (G6P) is generated when glucose is phosphorylated by hexokinase or glucokinase or by the conversion of glucose-1-phosphate by phosphoglucomutase during glycogenolysis. G6P lies at the beginning of both glycolysis and the pentose phosphate pathways. It also can be stored as glycogen when blood glucose levels are high.
-
ARA-290
ARA290 is a nonerythropoietic peptide engineered from erythropoietin,, and used for neurological disease treatment.
